• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Fennec Pharmaceuticals Inc. - Common Stock (NQ:FENC)

    9.240 +2.470 (+36.48%)
    Streaming Delayed Price Updated: 4:00 PM EDT, May 14, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about Fennec Pharmaceuticals Inc. - Common Stock

    < Previous 1 2 3 4 Next >
    These stocks are moving in today's session ↗
    Via Chartmill
    News headline image
    Fennec (FENC) Q1 2026 Earnings Call Transcript ↗
    Fennec (FENC) Q1 2026 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    Adherex Technologies Q1 Earnings Call Highlights ↗
    Adherex Technologies (NASDAQ:FENC) executives said Fennec Pharmaceuticals entered 2026 with stronger commercial momentum for PEDMARK, reporting higher first-quarter sales, positive operating cash flow... 
    Via MarketBeat
    Topics Earnings
    Fennec Pharmaceuticals (NASDAQ:FENC) Q1 Beat Overshadowed by Surging Costs ↗
    Via Chartmill
    Fennec Pharmaceuticals (NASDAQ:FENC) Reports Q4 2025 Revenue Growth but Misses Earnings Estimates ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For August 14, 2025 ↗
     
    Via Benzinga
    News headline image
    Fennec Pharmaceuticals Earnings Preview ↗
     
    Via Benzinga
    News headline image
    Fennec Pharmaceuticals's Earnings Outlook ↗
     
    Via Benzinga
    News headline image
    Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting
    From Fennec Pharmaceuticals Inc.
    Via GlobeNewswire
    News headline image
    Water Giant With $7 Billion in Revenue Draws $7.5 Million Investment, and Shares Are Surging This Year ↗
    This water solutions provider serves both consumers and businesses through recurring sales and a broad portfolio of regional brands. 
    Via The Motley Fool
    News headline image
    Earnings Scheduled For November 6, 2023 ↗
    Companies Reporting Before The Bell • Kosmos Energy (NYSE:KOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million. 
    Via Benzinga
    News headline image
    Payments Stock Down 30% Draws $6 Million Bet as Company Posts $4 Billion in Revenue ↗
    Euronet Worldwide runs a global payments platform, providing transaction processing and money transfer solutions across diverse markets. 
    Via The Motley Fool
    News headline image
    Solas Capital Loads Up On Kyndryl With 407,000 Shares Bought ↗
    This technology firm delivers IT infrastructure and managed solutions to major enterprises across multiple global industries. 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    Fennec Q2 Sales Jump 33 Percent ↗
    Via The Motley Fool
    News headline image
    Fennec (FENC) Q2 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings Intellectual Property
    News headline image
    Fennec Pharmaceuticals Inc (NASDAQ:FENC) Reports Mixed Q2 2025 Earnings with Revenue Slight Miss and Wider-Than-Expected Loss ↗
    Fennec Pharmaceuticals reported mixed Q2 2025 results, missing revenue estimates by 0.6% and posting a wider EPS loss. PEDMARK® growth and new accounts drove optimism despite financial... 
    Via Chartmill
    News headline image
    Nasdaq, S&P 500 Hit 6-Month Lows As Recession Fears Grow: What's Driving Markets Monday? ↗
    Stocks extended last week's losses on Monday as concerns over the U.S. economy continue to weigh on the market. The Nasdaq 100 saw the steepest declines, with Tesla, Inc. (NASDAQ:TSLA) and Palantir... 
    Via Benzinga
    Topics Economy Stocks
    News headline image
    Earnings Scheduled For March 10, 2025 ↗
     
    Via Benzinga
    News headline image
    Earnings Scheduled For May 13, 2025 ↗
     
    Via Benzinga
    News headline image
    Why BP Shares Are Trading Higher By 6%; Here Are 20 Stocks Moving Premarket ↗
     
    Via Benzinga
    News headline image
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Misses Revenue for Q2 2024 ↗
    FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
    Via InvestorPlace
    News headline image
    3 Dirt-Cheap Stocks Under $10 That Could EXPLODE! ↗
    These dirt cheap stocks under $10 have the potential to rise rapidly and create fortunes for bold investors. 
    Via InvestorPlace
    News headline image
    FENC Stock Earnings: Fennec Pharmaceuticals Beats EPS, Beats Revenue for Q1 2024 ↗
    FENC stock results show that Fennec Pharmaceuticals beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
    Via InvestorPlace
    News headline image
    FENC Stock Earnings: Fennec Pharmaceuticals Misses EPS, Beats Revenue for Q4 2023 ↗
    FENC stock results show that Fennec Pharmaceuticals missed analyst estimates for earnings per share but beat on revenue for the fourth quarter of 2023. 
    Via InvestorPlace
    News headline image
    Why Alibaba Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
     
    Via Benzinga
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Highlighted for Surprising Price Action
    Via Investor Brand Network
    Fennec Pharmaceuticals Inc. (NASDAQ: FENC) Making Surprising Moves in Monday Session
    Via Investor Brand Network
    News headline image
    Earnings Scheduled For March 21, 2024 ↗
    Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per share on revenue of $16.47 million. 
    Via Benzinga
    < Previous 1 2 3 4 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.